AI 기반 행동 요법 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the AI-powered behavioral therapy market is expected to grow from USD 1.68 billion in 2025 to USD 1.85 billion in 2026 and is forecast to reach USD 3.08 billion by 2031 at 10.73% CAGR over 2026-2031.

This report is Segmented by Product Type (AI Therapy Chatbots and Virtual Companions, and Others), Deployment Mode (Cloud, On-Premises), Application (Anxiety and Depression, and Others), Technology (Machine Learning, and Others), End-User (Individuals, and Others), and Geography (North America, Europe, and Others). The Market Forecasts are Provided in Terms of Value (USD).

Global AI-Powered Behavioral Therapy Market Trends and Insights

Rising Demand for Scalable Mental Health Access

The supply and demand gap in behavioral care has widened to a point that conventional hiring alone is unlikely to close in a commercially relevant period. Late 2024 data showed 6,807 designated mental health professional shortage areas in the United States, covering 137 million people, with only 27.3% of mental health needs being met and 6,800 additional practitioners needed just to remove existing shortage designations. Separate workforce modeling projects a decline in U.S. adult psychiatrist supply from 37,470 full-time equivalents in 2026 to 36,550 by 2038, even as annual demand rises to 73,330 and workforce adequacy falls from 71.9% to 49.8%. That imbalance makes the AI-powered behavioral therapy market structurally necessary for mild and moderate presentations, because digital tools can extend access without waiting for the workforce base to expand. The commercial implication is strongest in rural and non-metropolitan areas, where workforce adequacy is already far below metropolitan levels and the cost of in-person service expansion is harder to justify. In this setting, the AI-powered behavioral therapy market is gaining traction not because care systems prefer automation, but because the alternative is persistent untreated demand.

Employer-Grade Behavioral Care Benefits Expansion

Employer purchasing has become one of the clearest near-term distribution channels for the AI-powered behavioral therapy market. Lyra Health reported in March 2026 that 1 in 3 workers was merely surviving mentally and that 69% of benefits leaders said mental health challenges were materially reducing employee performance.A cohort study covering 589 U.S. employers using Spring Health's platform found that employer-sponsored digital mental health delivery produced recovery and remission outcomes aligned with evidence-based therapy norms. Businessolver's 2025 benefits survey also found that employee assistance programs ranked among the top 3 desired benefits, while employer coverage for mental health continued to broaden across large organizations. This is shifting channel power away from consumer app stores and toward payer, employer, and HR technology ecosystems that can buy at scale. As a result, the AI-powered behavioral therapy market is increasingly favoring vendors that can show enterprise-grade reporting, navigation, and outcomes tracking rather than only daily user engagement.

Clinical Validation and Outcome Attribution Gaps

Clinical evidence remains one of the main factors slowing broader institutional adoption in the AI-powered behavioral therapy market. The FDA's Digital Health Advisory Committee met in November 2025 to discuss generative AI-enabled mental health devices and recommended tools such as predetermined change control plans, randomized trials, and postmarket monitoring to manage model drift over time. Outcome attribution is also difficult when a patient improves in a mixed-care setting that includes a therapist, an app, medication, and employer navigation support at the same time. That uncertainty slows procurement because buyers want to know what part of the result belongs to the platform itself. Until real-world outcomes become easier to isolate and compare, the AI-powered behavioral therapy market will continue to face more caution from payers and clinical buyers than the underlying demand picture would otherwise suggest.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Assisted Clinical Triage for Shorter Wait Times
2. Under-Supplied Specialist Capacity in High-Burden Conditions
3. Privacy Sensitivity of Psychiatric and Behavioral Data

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

AI therapy chatbots and virtual companions held 49.23% of the AI-powered behavioral therapy market share in 2025, making them the largest product type by revenue. Their lead reflects 24/7 availability, low marginal interaction cost, and a format that can be deployed across employer, payer, and direct consumer channels without requiring large clinician capacity. The same pattern supports the AI-powered behavioral therapy market because chatbot products can expand access at scale while also building repeated engagement between formal care episodes.

Chatbots are also moving closer to care infrastructure than to stand-alone wellness tools. A randomized clinical trial also found that a conversational AI agent delivered greater anxiety reduction than group therapy, while stronger perceived therapeutic alliance predicted both engagement and symptom improvement. Cognitive behavioral therapy apps are the fastest-growing product type at 11.33% CAGR through 2031, which reflects stronger regulatory interest in structured protocol-based therapy software and a reimbursement environment that is becoming more open to digital adjuncts. Within the AI-powered behavioral therapy industry, that balance between conversational flexibility and structured CBT delivery is likely to define the next phase of product competition.

Cloud-based platforms commanded 62.17% share of the AI-powered behavioral therapy market size in 2025 and are also projected to grow at 11.68% CAGR through 2031. The lead comes from faster implementation, easier cross-device continuity, and the ability to update models and content centrally without disrupting the user experience. The AI-powered behavioral therapy market has favored cloud delivery because behavioral support depends on frequent interaction, real-time updates, and integration across mobile, web, and benefits channels.

On-premises deployment still matters in parts of the market where data residency, institutional control, and third-party processing limits remain strict. Government health systems, high-security psychiatric settings, and some European deployments continue to treat local control over sensitive behavioral information as a non-negotiable requirement. The AI-powered behavioral therapy market is therefore unlikely to move to a fully cloud-only structure, even if cloud remains the default for large-scale rollout. Instead, hybrid models are likely to persist because they let vendors serve enterprise buyers that want modern AI functionality without giving up direct control over sensitive data and governance workflows.

Complete Report Scope:

• By Product Type
  • AI Therapy Chatbots and Virtual Companions
  • Cognitive Behavioral Therapy Apps
  • AI-Driven Biofeedback Devices
  • AI-Powered Sleep and Stress Management Tools
  • Emotion Recognition and Monitoring Systems
• By Deployment Mode
  • Cloud-Based
  • On-Premises
• By Application
  • Anxiety and Depression
  • ADHD and Cognitive Disorders
  • Sleep Disorders
  • Substance Abuse and Addiction
  • Post-Traumatic Stress Disorder
• By Technology
  • Machine Learning
  • Natural Language Processing
  • Deep Learning
  • Emotion AI and Affective Computing
• By End-User
  • Individuals
  • Mental Health Clinics and Hospitals
  • Corporate Wellness Providers
  • Payers and Insurers
  • Academic and Research Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 51.55% of the AI-powered behavioral therapy market share in 2025, giving the region the largest global position by revenue. The region's lead comes from the strongest reimbursement infrastructure, the deepest employer-benefit adoption, and the clearest pressure to reduce behavioral care bottlenecks. U.S. mental health treatment costs also increased 10.9% from 2024 to 2025, which adds cost-containment pressure that can favor AI-supported lower-acuity models over specialist-only pathways. Canada and Mexico face similar provider shortages, but reimbursement systems for digital behavioral tools are still less developed, which keeps the regional story centered on the United States.

Europe does not lead on scale, but it remains important because regulatory structure is shaping which platforms can participate in the AI-powered behavioral therapy market. The United Kingdom introduced. Germany continues to matter because its digital therapeutic reimbursement system has become a reference point for structured clinical evidence and payer acceptance in Europe. The region is therefore acting less as a volume market today and more as a proving ground where compliance readiness and evidence discipline can determine market access.

Asia-Pacific is projected to grow at 14.27% CAGR through 2031, making it the fastest-growing region in the AI-powered behavioral therapy market. Growth is being supported by severe unmet need, lower specialist density in several major countries, and rising willingness to use AI tools as an early point of contact for mental health support. Japan's first commercial pediatric ADHD digital therapeutic launch in 2026 also signals that more formal software-based behavioral treatment pathways are entering the region, even if reimbursement models remain uneven. South America and the Middle East and Africa remain earlier-stage opportunities, where digital health investment is improving but AI behavioral therapy-specific coverage structures are still less established than in North America and parts of Europe.

1. AbleTo, Inc.
2. BetterHelp, LLC
3. Big Health, Inc.
4. Brightside Health, Inc.
5. Calm.com, Inc.
6. Cognoa, Inc.
7. Ellipsis Health
8. Headspace Health, Inc.
9. Kintsugi Mindful Wellness, Inc.
10. Koa Health, S.L.
11. Limbic
12. Lyra Health, Inc.
13. Meru Health
14. Quartet Health, Inc.
15. SilverCloud Health Ltd.
16. Spring Health, Inc.
17. Talkspace Inc.
18. Unmind Ltd.
19. Woebot Health
20. Wysa Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Demand for Scalable Mental Health Access
  • 4.2.2 Employer-Grade Behavioral Care Benefits Expansion
  • 4.2.3 AI-Assisted Clinical Triage for Shorter Wait Times
  • 4.2.4 Under-Supplied Specialist Capacity in High-Burden Conditions
  • 4.2.5 Reimbursement Acceptance for Digital Behavioral Interventions
  • 4.2.6 Multimodal Emotion AI Improving Engagement and Adherence
• 4.3 Market Restraints
  • 4.3.1 Clinical Validation and Outcome Attribution Gaps
  • 4.3.2 Privacy Sensitivity of Psychiatric and Behavioral Data
  • 4.3.3 Model Hallucination and Unsafe Escalation Risk
  • 4.3.4 Workflow Friction in Provider and Payer Integration
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Product Type
  • 5.1.1 AI Therapy Chatbots and Virtual Companions
  • 5.1.2 Cognitive Behavioral Therapy Apps
  • 5.1.3 AI-Driven Biofeedback Devices
  • 5.1.4 AI-Powered Sleep and Stress Management Tools
  • 5.1.5 Emotion Recognition and Monitoring Systems
• 5.2 By Deployment Mode
  • 5.2.1 Cloud-Based
  • 5.2.2 On-Premises
• 5.3 By Application
  • 5.3.1 Anxiety and Depression
  • 5.3.2 ADHD and Cognitive Disorders
  • 5.3.3 Sleep Disorders
  • 5.3.4 Substance Abuse and Addiction
  • 5.3.5 Post-Traumatic Stress Disorder
• 5.4 By Technology
  • 5.4.1 Machine Learning
  • 5.4.2 Natural Language Processing
  • 5.4.3 Deep Learning
  • 5.4.4 Emotion AI and Affective Computing
• 5.5 By End-User
  • 5.5.1 Individuals
  • 5.5.2 Mental Health Clinics and Hospitals
  • 5.5.3 Corporate Wellness Providers
  • 5.5.4 Payers and Insurers
  • 5.5.5 Academic and Research Institutes
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 AbleTo, Inc.
  • 6.3.2 BetterHelp, LLC
  • 6.3.3 Big Health, Inc.
  • 6.3.4 Brightside Health, Inc.
  • 6.3.5 Calm.com, Inc.
  • 6.3.6 Cognoa, Inc.
  • 6.3.7 Ellipsis Health
  • 6.3.8 Headspace Health, Inc.
  • 6.3.9 Kintsugi Mindful Wellness, Inc.
  • 6.3.10 Koa Health, S.L.
  • 6.3.11 Limbic
  • 6.3.12 Lyra Health, Inc.
  • 6.3.13 Meru Health
  • 6.3.14 Quartet Health, Inc.
  • 6.3.15 SilverCloud Health Ltd.
  • 6.3.16 Spring Health, Inc.
  • 6.3.17 Talkspace Inc.
  • 6.3.18 Unmind Ltd.
  • 6.3.19 Woebot Health
  • 6.3.20 Wysa Ltd.

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment